Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Paynova in conjunction with raising of capital and change in listing
Mandate

Vinge advises Paynova in conjunction with raising of capital and change in listing

June 07, 2022 Capital Markets and Public M&A

Vinge has advised Paynova AB, under change of name to Sileon AB, in connection with a fully subscribed rights issue valued at approximately SEK 70 million.  

In connection with the issue, Paynova has also made public their intention to implement a change of listing from NGM Regulated to Nasdaq First North Growth Market.

Vinge’s team consisted of, among others, Anders Strid, Edin Agic (project manager), Adrian Filipovic and Amelia Rihs.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

 HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

 Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

 Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026